Spyre Therapeutics, Inc. (SYRE) Total assets 2016–2025
Spyre Therapeutics, Inc. (SYRE) total assets at each fiscal year-end, per SEC filings.
$777.8MFY2025 · since FY2016: $67.1M → $777.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $777.8M | +27.8% |
| FY2024 | $608.5M | +78.0% |
| FY2023 | $341.9M | +380.5% |
| FY2022 | $71.1M | -35.3% |
| FY2021 | $109.9M | -32.0% |
| FY2020 | $161.6M | +94.3% |
| FY2019 | $83.2M | +7.0% |
| FY2018 | $77.7M | +38.6% |
| FY2017 | $56.1M | -16.4% |
| FY2016 | $67.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice